Kunjbihari Sulakhiya

Amarkantak, MP, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Next-generation intranasal delivery nano-platforms for targeted brain therapy of Alzheimer's disease.

Next-generation intranasal delivery nano-platforms for targeted brain therapy of Alzheimer's disease.

Journal: Nanomedicine (London, England)
Published: June 16, 2026

Identification of Potential Compounds from Medicinal Plants using Molecular Docking and Molecular Dynamics Simulation with Special Reference to Autism Spectrum Disorder.

Identification of Potential Compounds from Medicinal Plants using Molecular Docking and Molecular Dynamics Simulation with Special Reference to Autism Spectrum Disorder.

Journal: Current computer-aided drug design
Published: December 31, 2025

Hyperprolactinemia and Tau Pathology: Unravelling Neuroendocrine Dysregulation for Therapeutic Targeting.

Hyperprolactinemia and Tau Pathology: Unravelling Neuroendocrine Dysregulation for Therapeutic Targeting.

Journal: Current neurovascular research
Published: November 18, 2025

Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders.

Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders.

Journal: Frontiers in medicine
Published: July 12, 2024

Madhuca indica oil-entrapped buoyant galactomannan hydrogel microspheres for controlling epileptic seizures.

Madhuca indica oil-entrapped buoyant galactomannan hydrogel microspheres for controlling epileptic seizures.

Journal: International journal of biological macromolecules
Published: February 03, 2024

Probing the links: Long non-coding RNAs and NF-κB signalling in atherosclerosis.

Probing the links: Long non-coding RNAs and NF-κB signalling in atherosclerosis.

Journal: Pathology, research and practice
Published: July 06, 2023

Autism Spectrum Disorders: A Recent Update on Targeting Inflammatory Pathways with Natural Anti-Inflammatory Agents.

Autism Spectrum Disorders: A Recent Update on Targeting Inflammatory Pathways with Natural Anti-Inflammatory Agents.

Journal: Biomedicines
Published: October 19, 2022

Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.

Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.

Journal: Current drug safety
Published: August 17, 2022

Transcriptional Factors and Protein Biomarkers as Target Therapeutics in Traumatic Spinal Cord and Brain Injury.

Transcriptional Factors and Protein Biomarkers as Target Therapeutics in Traumatic Spinal Cord and Brain Injury.

Journal: Current neuropharmacology
Published: January 23, 2020

The energetic brain - A review from students to students.

The energetic brain - A review from students to students.

Journal: Journal of neurochemistry
Published: March 13, 2019

Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus.

Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus.

Journal: Pharmaceutical biology
Published: March 24, 2018

Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy.

Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy.

Journal: Frontiers in pharmacology
Published: December 11, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026